FDA product code PJA: Coronary Vascular Physiologic Simulation Software
PJA is the FDA product code for coronary vascular physiologic simulation software. It is a Class II device, regulated under 21 CFR 870.1415 and reviewed by the Cardiovascular panel. FDA has cleared 9 510(k) submissions under PJA, 4 in the last five years, from 3 different applicants. The average 510(k) review took 127 days (median 114); 110 days on average over the last three years. 1 De Novo request was granted under it.
Definition
A coronary vascular physiologic simulation software device is intended to aid in the identification of functionally significant cardiovascular disease.
Classification
| Field | Value |
|---|---|
| Device name | Coronary Vascular Physiologic Simulation Software |
| Device class | Class II |
| Regulation | 21 CFR 870.1415 |
| Review panel | CV — Cardiovascular |
| Medical specialty | Cardiovascular |
| Premarket route | 510(k) |
510(k) clearances per year for PJA
| Year | Clearances | Avg. review days |
|---|---|---|
| 2018 | 1 | 129 |
| 2019 | 1 | 128 |
| 2021 | 1 | 57 |
| 2022 | 2 | 220 |
| 2025 | 1 | 114 |
| 2026 | 1 | 106 |
Compare with all 510(k) review times · Search every PJA clearance
Top PJA applicants
| Applicant | Clearances | Latest |
|---|---|---|
| HeartFlow, Inc. | 7 | 2025-07-18 |
| Elucid Bioimaging, Inc. | 1 | 2026-09-29 |
| Keyamed Na, Inc. | 1 | 2022-04-01 |
Most recent PJA clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K262015 | Elucid Bioimaging, Inc. | Elucid FFR-IQ (B.1) | 2026-09-29 | 106 |
| K250902 | HeartFlow, Inc. | HeartFlow Analysis | 2025-07-18 | 114 |
| K213857 | HeartFlow, Inc. | HeartFlow Analysis | 2022-10-14 | 308 |
| K213657 | Keyamed Na, Inc. | DEEPVESSEL FFR | 2022-04-01 | 133 |
| K203329 | HeartFlow, Inc. | HeartFlow Analysis | 2021-01-08 | 57 |
Recalls for PJA devices
FDA recall records list no recalls for product code PJA.
Frequently asked questions
What is FDA product code PJA?
PJA is the FDA product code for coronary vascular physiologic simulation software. It is a Class II device, regulated under 21 CFR 870.1415 and reviewed by the Cardiovascular panel.
What device class is PJA?
Class II, regulation 21 CFR 870.1415. Typical premarket route: 510(k).
How long does a 510(k) take for product code PJA?
Across 9 cleared submissions the average was 127 days from receipt to decision (median 114).
Which companies have the most PJA clearances?
HeartFlow, Inc. (7); Elucid Bioimaging, Inc. (1); Keyamed Na, Inc. (1).
Next steps
- Run an FDA pathway report with predicate devices for product code PJA
- Run a recall and safety report across every PJA manufacturer
- Watch product code PJA for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times